Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Aescin-Based Herbal Extract (Reparil) for Postoperative Sequelae After Mandibular Third Molar Surgery [NA]

View source ↗

Summary

Clinical trial evaluating an aescin-based herbal extract (Reparil) for postoperative sequelae after mandibular third molar surgery, focusing on pain, facial swe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Reparil (Aescin (aescin-based extract))

Snippet

Sponsor: Oman Medical Speciality Board | Conditions: Postoperative Pain, Facial Swelling | NA | Status: RECRUITING